Oncoguide System: A computerized interactive assistance system for the diagnosis and treatment of CML/MPN and MDS D. This is an ASCO Meeting Abstract from the 2016 ASCO Annual Meeting I. This abstract ...

To support the validation and verification of new assays and to challenge the existing assays in oncology testing, Thermo Fisher Scientific launches Thermo Scientific Acrometrix BCR-ABL Panel. The ...

Incidence and survival of chronic myelomonocytic leukemia (CMML) in the United States (US). This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full ...

In accordance to its targeted timeline, Cepheid CPHD recently launched its Xpert BCR-ABL Ultra test commercially outside the U.S. The company will initiate shipment of this test as a CE-IVD product ...

In vitro diagnostic may be used to monitor disease progression and therapy in Ph+ CML patients. Asuragen and Life Technologies obtained a CE-mark and have launched the BCR/ABL1 Quant™ Test in Europe.

You might see the BCR-ABL1 gene written in a more scientific way BCR::ABL1. Genetic tests are also done to look for other abnormal chromosomes. You might hear these tests called cytogenetic tests, ...

BELFAST, UNITED KINGDOM--(Marketwire - Mar 12, 2013) - Labceutics Inc. announced today that it has partnered with Asuragen Inc., a leading molecular diagnostics company, to conduct an international ...

ARIAD Pharmaceuticals, Inc.Kendra Adams, 617-503-7028orLiza Heapes, 617-621-2315orKatherine Clock, 503-459-4974 and (NASDAQ: ARIA) today announced that MolecularMD has voluntarily withdrawn its ...